维普中文期刊产品整合服务
16篇 您的检索式:作者名="Spier CM"
    题名 作者 年代 出处 被引量
1Phase II study of rituximab plus three cycles of GHOP and involved-field radiotherapy lot pa dents with limited-stage aggressive B-cell lymphoma: Southwcst Oncology Group study 0014显示文摘Persky DO UngerJM Spier CM 2008J Clin Oncol2008,26,14:1
2Myelomonocytic anti- gen positive multiple myeloma显示文摘Grogan TM Durie BG Spier CM 1989Blood1989,73,3:1
3Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course显示文摘Lippman SM Spier CM Miller TP 1990Mod Pathol1990,3,:1
4NCAM ( CD56)-positive malignant lymphoma 显示文摘Kern WF Spier CM Miller TP 1993Leuk Lymphoma1993,12,12:1
5Phase Ⅱ study of ritux imab plus three cycles of CHOP and involved-field radiotherapy for patients with limited stage aggressive B-cell lymphoma: Southwest Oneology Group study0014显示文摘Persky DO Unger JM Spier CM 2008J Clin Oncol2008,26,14:1
6Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement显示文摘Kern WF Spier CM Hanneman EH 1992Blood1992,79,9:1
7Phase 2 trial of combined cisplatin,etoposide,gemcitabine,and methylprednisolone(PEGS) in peripheral T-cell non-Hodgkin lymphoma:Southwest Oncology Group Study S0350显示文摘Mahadevan D Unger JM Spier CM 0,,02:1
8Myelomonocytic antigen positive multiple myeloma 显示文摘Grogan TM Durie BG Spier CM 1982Blood1982,73,:1
9Multidrug resistance in acute leukemia a conserved physiologic function 显示文摘 Spier CM 1992Leukemia and Lymphoma1992,8,:1
10Myelomonocytic antigen positive multiple myeloma显示文摘Grogan TM Durie BG Spier CM 1989Blood1989,73,3:1
11Phase II study of rituximab plus three cycles of CHOP and involved- field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014 显示文摘Persky DO Unger JM Spier CM 2008J Clin Oncol2008,26,14:1
12Phase II study of rituximab plus three cycles of CHOP and invo|ved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014显示文摘Persky DO Unger JM Spier CM 2008J Clin Oncol2008,26,14:1
13Phase 2 trial of combined cisplatin,etoposide,gemcitabine,and methylprednisolone(PEGS)in peripheral T-cell non-Hodgkin lymphoma:Southwest Oncology Group Study S0350显示文摘Mahadevan D Unger JM Spier CM 2013Cancer2013,119,2:1
14Expression of the multidrug resistancegene product(P-glycoprotein)in myelodysplasia is associated with a stem cell phenotype显示文摘List A Spier CM Cline A 1991British Journal of Haematology1991,78,:1
15The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in diffuse large cell lymphoma 显示文摘Spier CM Grogan TM L ippman SM 1988Am J Pathol1988,133,:1
16P glycuprotein expression in human plasma cell myeloma:corre- lation with prior chemo therapy显示文摘Grogan TM Spier CM Salmon SE Matzner M Rybski J 1993Blood1993,81,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费